1. A convenient synthesis of 24-methylene[23,25-3H3]dihydrolanosterol is described. 2. A general anaerobic-aerobic method for the incorporation of sterols into whole yeast cells is also described and illustrated by experiments with 3H-labelled lanosterol. 3. The method was used to convert labelled 24-methylenedihydrolanosterol into ergosterol, in good yield, by Saccharomyces cerevisiae. 4. Degradation of the biosynthetic ergosterol provided confirmation of the conversion, which supports the proposed mechanism for the biosynthesis of the ergosterol side chain. 5. Mechanisms for the further conversion of the 24-methylene side chain into the ergosterol side chain are discussed and it was shown that a compound, [3OC-3H1]-ergost-7-en-3,B-ol, with a fully saturated side chain, can also be efficiently incorporated into ergosterol. 6. This result was confirmed by a procedure involving formation of the 5,8-epidioxide and subsequently the 5,8-epidioxy-22,23-epoxide of the biosynthetic ergosterol.
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The side chain of ergosterol (I) contains two unique features that are not found in the side chain of cholesterol. The first is the presence of an 'extra' carbon atom at position C-24 and the second is the existence of a double bond between C-22 and C-23. Early work by Parks (1958) established that the extra carbon atom at C-24 is derived from S-adenosylmethionine. Later work by Lederer (1964) re- vealed that only two of the three original hydrogen atoms from the methyl group of S-adenosylmethionine were incorporated into the C-28 methvl group of ergosterol. This observation led us and others (Akhtar, Parvez & Hunt, 1966a; Castle, Blondin & Nes, 1963; Lederer, 1964; Clayton, 1965; Goad, Hammam, Dennis & Goodwin, 1966) to consider a mechanism of the type outlined in Scheme 1 for the C-alkylation step in ergosterol biosynthesis. Evidence in favour of this mechanism was provided by our work (Akhtar, Hunt & Parvez, 1966b) and independent observations on the mechanism were subsequently reported by a number of workers (Goulston, Goad & Goodwin, 1967; Castle, Blondin & Nes, 1967; Russell, van Aller & Nes, 1967; Raab, de Souza & Nes, 1968) . The mechanism presented in Scheme 1 should predict the intermediary role of the side chain of type (V) in the biosynthesis of ergosterol, and indeed a sterol with this side chain has been isolated from yeast (Barton, Harrison & Widdowson, 1968) .
In this paper we report the synthesis of tritiated 24-methylenedihydrolanosterol (XI) and its conversion into ergosterol by whole cells of the yeast Saccharomyces cerevisiae. We also describe experiments that demonstrate the further conversion of the 24-methylene side chain of type (V) into the ergosterol side chain. Preliminary accounts of a part of this work, from this laboratory and elsewhere, have been published (Akhtar et al. 1966a; Barton, Harrison & Moss, 1966) .
RESULTS AND DISCUSSION
Incorporation of sterols into yeast cells. The pathway leading to the biosynthesis of ergosterol in yeast takes place without a requirement for oxygen up to the stage of squalene. The conversion of squalene into ergosterol involves a number of oxygen-dependent reactions. We have observed that anaerobically growing yeast cells, deficient in endogenous sterols, can incorporate efficiently a variety of sterols from the medium. This has enabled us to develop an 'anaerobic-aerobic' method for the conversion of precursor sterols into ergosterol in good yield. This method is a modification of the method of Kodicek (1959) .
Synthesis of tritiated 24-methylenedihydrolanosterol and its conversion into ergosterol. 24-Methylenedihydrolanosterol (XI), tritiated at positions C-23 and C-25, was synthesized by the sequence of reactions shown in Scheme 2. 24-Methylenedihydrolanosterol was converted by using the anaerobic-aerobic method into ergosterol in 6-2% yield: evidence for the conversion is described in the Experimental section.
Observations on the mechanism of the introduction of the C-22-C-23 double bond. Akhtar Hunt (1968) discussed a number ofgeneral pathways formation of the C-22-C-23 double bond followed for the conversion of structure (V) into structure by the reduction of the C-24-C-28 double bond;
(XIII) (Scheme 3).
pathway C shows the reverse of the oxidationThe three most likely possibilities are displayed reduction sequence. Indirect evidence provided by in Scheme 3. Pathway A involves a series of Katsuki & Bloch (1967) the 5,7-diene system and insertion of the C-22-C-23 double bond, it was necessary to establish that the radioactivity was associated with the compound having both these features. The conversion of the biosynthetic ergosterol acetate into the epidioxide (XIX) occurred with complete retention of radioactivity, thus showing the presence of the diene system in the radioactive compound. The presenoe of the C-22-C-23 double bond in the radioactive compound was established by a new method that involves conversion of the epidioxide (XIX) into the epoxy-epidioxide (XX). This conversion was once again accompanied by the retention of radioactivity. In the epoxidation ofthe C-22-C-23 double bond two epoxides were formed and were readily separated by chromatography. Professor D. H. R. Barton (personal communication) has noted a similar phenomenon with a related compound. The conversion of compound (XVI) into ergosterol is in agreement with the previous conclusion (Akhtar et al. 1968 ) that the enzymes participating in the formation of the C-22-C-23 double bond in ergosterol biosynthesis do not require the activation of the C-24-C-28 double bond.
The observation (Smith, Goad & Goodwin, 1968) that formation of the C-22-C-23 double bond of poriferasterol (and probably ergosterol also) is accompanied by the elimination of two ci8-oriented hydrogens, supports the proposal (Dewhurst & Akhtar, 1967 ) that the mechanism is probably analogous to that involved in the introduction of the C-5-C-6 double bond of cholesterol (Dewhurst & Akhtar, 1967) and the double bonds of certain long-chain fatty acids (Schroepfer & Bloch, 1965; Morris, Harris, Kelly & James, 1968 Preparation of 3fl-acetoxy-25-bromolanost-8-en-24-one (VIII; R=CH3.CO). Conc. HBr (0-5ml.) was added to a suspension of 3fl-acetoxy-24,25-epoxylanost-8-ene (VII; R=CH3.CO) (500mg.) in acetic acid (12-5ml.) at room temperature and the reaction mixture was left standing until clear (5min.). The reaction was stopped by addition of cold water and the precipitated bromohydrin was extracted with ether. The organic layer was dried with Na2SO4 and the solvent was removed under vacuum. The resulting solid was oxidized in acetone with Jones reagent (0-4ml.) (Bowden, Heilbron, Jones & Weedon, 1946) . The excess of reagent was decomposed with methanol. The product was extracted with ether, washed with aq. NaHCO3 and dried with Na2SO4. The ethereal solution was evaporated to dryness and the residue was chromatographed on silica gel (20g.) with benzene-light petroleum (b.p. 80-100°) (3:2, v/v) as eluent. This ratio was finally increased to 9:1 (v/v). The compound (VIII; R= CH3-CO) was obtained in pure form (170mg.), m.p. 1350 (Found: C, 68-0; H, 9-0; Br, 13-8. C32H51BrO3 requires C, 68-0; H, 9 0; Br, 14-0%).
Preparation of 3fl-acetoxylanost- 24-methylene[23,25-3H3] dihydrolanosterol (XI; R= H) into ergosterol (taking into account the loss of one tritium atom from C-23, the conversion is 9.3%).
Degradation of biosynthetic ergosterol derived from 24-methylene [23,25-3H3] dihydrolanosterol. Biosynthetic ergosterol (500mg.; 98c.p.m./mg.) was suspended in acetic acid (5 ml.) and ozone was bubbled until all the solid had dissolved (2hr.). The solution was cooled to 100, zinc dust (1-25g.) was added and the reaction mixture stirred for 1 hr. Zinc was filtered off and washed with acetic acid. 2,3-Dimethylbutyraldehyde was isolated and converted into the dimedone derivative as described by Akhtar et al. (1966b) . The derivative (100mg.) was recrystallized from ethanol-water and had m.p. 150-152°and specific radioactivity 107 c.p.m./ mg.
Preparation of ergost-7-en-3gf-ol (A7-ergostenol) (XVI; R= H). Ergosterol acetate (1-5g.), dissolved in ethyl acetate (50ml.), was reduced at room temperature in the presence of pre-reduced Adams catalyst (200mg.) in ethyl acetate (5ml.) until 2mol.prop. of hydrogen had been taken up (Wieland & Benend, 1943) . After filtering off of the catalyst, the solvent was removed and the solid crystallized from ether-methanol to yield ergost-7-en-3#-ol acetate (XVI; R= CH3.CO) (1-3g.) . The acetate (lg.) was dissolved in dry ether, treated with LiAlH4 (300mg.) and refluxed for 1 hr. Excess of LiAlH4 was decomposed with methanol and the product was extracted with ether. Crystallization from ether-methanol gave ergost-7-en-3fl-ol (XVI; R=H) (600mg.), m.p. 1400; Wieland & Benend (1943) quote 1480.
Preparation of ergost-7-en-3-one (XVIII). Ergost-7-en-3,B-ol (XVI; R=H) (200mg.) in acetone (20ml.) was cooled to 150 and treated with Jones reagent (0-2 ml.). The reaction mixture was stirred for 10min. Excess of reagent was decomposed with methanol and the product was extracted with ether. The extracts were washed with aq.
NaHCO3 and water and dried with Na2SO4. Crystallization from ether-methanol gave the ketone (XVIII) (160mg.).
Preparation of [3a-3Hi]ergost-7-en-3P-ol (X VII; R= H).
Ergost-7-en-3-one (XVIII) (158mg.), dissolved in methanol (20ml.), was treated at room temperature with tritiated NaBH4 (2-3mg.). After 30min. non-radioactive NaBH4 (10-15mg.) was added and the mixture allowed to stand for a further 60 min. The product was precipitated by addition of excess of water and extracted with ether. Crystallization from ether-methanol gave compound (XVII; R= H) (60mg.), specific radioactivity 1 44 x 107c.p.m./mg.
Conversion of R=H) into ergosterol. R=H) (1 mg.; 1-42 x 107 c.p.m.) was incubated with Saccharomyces cerevisiae LK2G12 as described below and ergosterol was isolated by the method of Akhtar et al. (1966a) . The biosynthetic ergosterol was diluted with carrier ergosterol (2g.) and crystallized to constant specific radioactivity (1058 c.p.m./mg.; total radioactivity 1058x2000=2-12x 106 c.p.m.; 14-9% conversion).
Preparation of 5c,8ae-epidioxyergosta-6,22-dien-3fg-ol acetate (XIX)from biosynthetic ergosterol. Ergosterol acetate (200mg.) in ethanol (30ml.) containing eosin (2-3mg.) was irradiated under reflux with a 150w incandescent lamp while 02 was bubbled through the solution. The reaction was stopped when the solution ceased to show an absorption maximum at 282nm. The product was crystallized from ether-methanol to give compound (XIX) (100mg.), m.p. 196-198°; Clayton, Henbest & Jones (1953) quote m.p. 195-200° . The parent ergosterol had a specific radioactivity of 4-19 x 105c.p.m./m-mole and the epoxide had the same specific radioactivity.
Preparation of 5ce,8xc-epidioxy-22,23-epoxyergost-6-en-33-ol acetate (XX). m-Chloroperbenzoic acid (80mg.) was added to a solution of5x,8oc-epidioxyergosta-6,22-dien-3/3-ol acetate (XIX) (50mg.; 4-19 x 105c.p.m./m-mole) in chloroform (5ml.) at 00 and the reaction was allowed to proceed for 14 hr. The excess ofper-acid was decomposed by washing with aq. Na2SO3, NaHCO3, NaCl and finally water. The solution was dried and the solvent removed. Crystallization of the residue from ether-methanol gave a solid (30mg.), which was chromatographed on a preparative t.l.c. plate (silica gel H) into two bands A (mobility 8 cm.) and B (mobility 6-5 cm.), which were eluted and crystallized separately. Analysis of the compound A obtained from band A showed C, 73-06; H, 9-56; C30H4605 (monoepoxide) requires C, 74-04; H, 9-53%. Compound B from band B showed C, 73-33; H, 9-84; C30H4605 (monoepoxide) requires C, 74-04; H, 9.53%. The n.m.r. spectra for both the compounds A and B showed the presence of the C-6-C-7 Table 1 . Position of protons at C-6 and C-7 and at C-22 and C-23 in the n.m.r. spectra of various related steroid derivatives Compound 5oc,80c-Epidioxyergosta-6,22-dien-3f3-ol acetate Ergost-22-ene-5c,8c,3fl-triol 3-acetate 5ao,8oc-Epidioxycholest-6-en-3,B-ol acetate 5x,8a-Epidioxy-22,23-epoxyergost -6 -en -3/3 -ol acetate (isomer A) 5a,8cx-Epidioxy-22,23-epoxy-
Position of C-6 and C-7 protons (p.p.m.) 6-1-6-6
Position of C-22 and C-23 protons (p.p.m.) 5-1-5-3
5-1-5-3
6-1-6-6
6-1-6-6 double bond and the absence of the C-22-C-23 double bond. This was confirmed by the n.m.r. spectra of related compounds as shown in (Akhtar et al. 1966b ) (1mg.; 8-3 x 105c.p.m.) emulsified in Tween 80 (15mg.) (Tchen, 1963) was added to a sterilized medium (Klein, Eaton & Murphy, 1954) separately to two flasks (41. in each). After the addition of an inoculum (4-6mg.) of yeast Saccharomyces cerevisiae LK2G12, both the flasks were incubated at 300, one under an atmosphere of 02 and the other under an atmosphere of N2. After 48hr. incubation, l1. of medium was taken from each flask; the cells were harvested and saponified and the non-saponifiable fraction was extracted. The anaerobic cells showed a total incorporation of 5 68 x 105 c.p.m. (=68-4%), and the aerobically grown cells showed a total incorporation of 1-92x 105c.p.m. (=23-1%). At this stage the N2 supply of the anaerobic incubation vessel was replaced by 02 and the two flasks were incubated for a further 24hr. The cells from the anaerobic-aerobic incubation and from the totally aerobic incubation were harvested and saponified and the sterols were extracted separately. At this stage (end of 72 hr. incubation), the anaerobicaerobic cells showed a total incorporation of 93-3% of lanosterol, whereas the aerobically grown cells showed a total incorporation of 28% of lanosterol. In each case the non-saponifiable fraction was diluted with ergosterol (1g.) and crystallized to constant specific radioactivity. The anaerobic-aerobic experiment gave ergosterol having 290 c.p.m./mg. (total radioactivity 2-9 x 105 c.p.m.), which represents 34.9% conversion of lanosterol into ergosterol, whereas the aerobic experiment gave ergosterol having 62 c.p.m./mg. (total radioactivity 0-62 x 105 c.p.m.), which represents 7-4% conversion.
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